Detalhe da pesquisa
1.
Long-term evaluation of the safety and efficacy of recombinant human pentraxin-2 (rhPTX-2) in patients with idiopathic pulmonary fibrosis (IPF): an open-label extension study.
Respir Res
; 23(1): 129, 2022 May 21.
Artigo
Inglês
| MEDLINE | ID: mdl-35597980
2.
Pharmacokinetics and Exposure-Response Analysis of RG7667, a Combination of Two Anticytomegalovirus Monoclonal Antibodies, in a Phase 2a Randomized Trial To Prevent Cytomegalovirus Infection in High-Risk Kidney Transplant Recipients.
Antimicrob Agents Chemother
; 62(2)2018 02.
Artigo
Inglês
| MEDLINE | ID: mdl-29133549
3.
Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of RG7667, a Combination Monoclonal Antibody, for Prevention of Cytomegalovirus Infection in High-Risk Kidney Transplant Recipients.
Antimicrob Agents Chemother
; 61(2)2017 02.
Artigo
Inglês
| MEDLINE | ID: mdl-27872061
4.
Phase 2 Randomized Trial of the Safety and Efficacy of MHAA4549A, a Broadly Neutralizing Monoclonal Antibody, in a Human Influenza A Virus Challenge Model.
Antimicrob Agents Chemother
; 61(11)2017 11.
Artigo
Inglês
| MEDLINE | ID: mdl-28807912
5.
Two Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single-Ascending-Dose Studies To Investigate the Safety, Tolerability, and Pharmacokinetics of an Anti-Influenza A Virus Monoclonal Antibody, MHAA4549A, in Healthy Volunteers.
Antimicrob Agents Chemother
; 60(9): 5437-44, 2016 09.
Artigo
Inglês
| MEDLINE | ID: mdl-27381392
6.
Phase 1 Randomized, Double-Blind, Placebo-Controlled Study of RG7667, an Anticytomegalovirus Combination Monoclonal Antibody Therapy, in Healthy Adults.
Antimicrob Agents Chemother
; 59(8): 4919-29, 2015 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-26055360
7.
Reply to Hunsberger and Memoli, "Efficacy Analysis in Healthy-Volunteer Influenza Challenge Trials: Intention To Treat".
Antimicrob Agents Chemother
; 62(1)2018 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29269431
8.
Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial.
Lancet
; 378(9802): 1547-59, 2011 Oct 29.
Artigo
Inglês
| MEDLINE | ID: mdl-21908036
9.
Effect of dalcetrapib plus pravastatin on lipoprotein metabolism and high-density lipoprotein composition and function in dyslipidemic patients: results of a phase IIb dose-ranging study.
Am Heart J
; 163(3): 515-21, 521.e1-3, 2012 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-22424025
10.
Rationale and design of dal-PLAQUE: a study assessing efficacy and safety of dalcetrapib on progression or regression of atherosclerosis using magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission tomography/computed tomography.
Am Heart J
; 162(2): 214-221.e2, 2011 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-21835280
11.
Safety and tolerability of dalcetrapib (RO4607381/JTT-705): results from a 48-week trial.
Eur Heart J
; 31(4): 480-8, 2010 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-20097702
12.
Fenebrutinib in H1 antihistamine-refractory chronic spontaneous urticaria: a randomized phase 2 trial.
Nat Med
; 27(11): 1961-1969, 2021 11.
Artigo
Inglês
| MEDLINE | ID: mdl-34750553
13.
An Open-Label, Phase II Study of the Safety of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis (PIPF-002).
Pulm Ther
; 4(1): 59-71, 2018 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-32026243
14.
Pharmacokinetics of MHAA4549A, an Anti-Influenza A Monoclonal Antibody, in Healthy Subjects Challenged with Influenza A Virus in a Phase IIa Randomized Trial.
Clin Pharmacokinet
; 57(3): 367-377, 2018 03.
Artigo
Inglês
| MEDLINE | ID: mdl-28639229
16.
Rationale and design of dal-VESSEL: a study to assess the safety and efficacy of dalcetrapib on endothelial function using brachial artery flow-mediated vasodilatation.
Curr Med Res Opin
; 27(1): 141-50, 2011 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-21128879
17.
Safety and tolerability of dalcetrapib.
Am J Cardiol
; 104(1): 82-91, 2009 Jul 01.
Artigo
Inglês
| MEDLINE | ID: mdl-19576325